{"id":"W7117315492","doi":"10.1016/j.iotech.2025.101210","title":"126P Neoadjuvant (neoadj) nivolumab (N) + chemotherapy (C) in patients (pts) with resectable NSCLC: Outcomes by subsequent immunotherapy (IO) in CheckMate 816","year":2025,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Trinity College; McGill University Health Centre","funders":"","keywords":"Nivolumab; Chemotherapy; Immunotherapy; Chemoimmunotherapy; Neoadjuvant therapy; MEDLINE","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006362041,0.0006524675,0.001628944,0.001832936,0.0001513141,0.00003158068,0.0007561306,0.001263267,0.0003616773],"category_scores_gemma":[0.00008671473,0.000547574,0.0002027672,0.002414639,0.0009075335,0.0001822791,0.0001491366,0.001152402,0.00002968559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002624397,"about_ca_system_score_gemma":0.000840112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001845771,"about_ca_topic_score_gemma":0.001368285,"domain_scores_codex":[0.9959831,0.0001820645,0.001284869,0.0009575203,0.0003413816,0.001251084],"domain_scores_gemma":[0.997905,0.000154287,0.0003798165,0.001294752,0.0001999978,0.00006611829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02394617,0.003122571,0.6367442,0.00007176663,0.0008299974,0.0001474177,0.0005202562,0.00000338154,0.09507343,0.0002853609,0.003706102,0.2355493],"study_design_scores_gemma":[0.1333524,0.009217094,0.5455231,0.001061528,0.0001036774,0.0001298674,0.001407103,0.00005318451,0.06184969,0.001086521,0.2449726,0.001243209],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9672557,0.009640004,0.00007240554,0.01635711,0.0005704908,0.002056646,0.0000229606,0.0003527425,0.003671986],"genre_scores_gemma":[0.9877149,0.003116033,0.0006478516,0.004390386,0.0000164528,0.0006706323,0.00008823151,0.0001065453,0.003248896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2412665,"threshold_uncertainty_score":0.9996976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005142110023032019,"score_gpt":0.2744393243525463,"score_spread":0.2692972143295143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}